Vertex Pharmaceuticals Inc. logo

VRTX

Vertex Pharmaceuticals Inc.

$515.44
+0.17%
Last updated 1:10 AM
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc is a Biotechnology company listed on NASDAQ NMS - GLOBAL MARKET.

Industry
Biotechnology
Exchange
NASDAQ NMS - GLOBAL MARKET
Market Cap
$121.1B
P/E Ratio
30.1
Cash on Hand
$6.6B(positive)
Shares Outstanding
253.8M shares
Currency
USD
Visit website →

About

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$4.83$4.73
Q1 2026$4.40$4.47
Q4 2025$5.17$5.03
Q3 2025$4.65$4.80

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$374.17 – $560.25

The lowest and highest price this stock has traded at over the past year.

Profit Margin
35.0%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+10.2%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.28

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 36 analysts

Next Earnings
Nov 2, 2026

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

SACHS BRUCE I
Aug 27, 2026
Sold 6,000
Sachdev Amit
Jul 21, 2026
Bought 8,251
Tatsis Ourania
Jul 21, 2026
Bought 8,251
SACHS BRUCE I
Jul 15, 2026 • $475.28/share
Bought 100
Garber Alan M
Jul 15, 2026 • $475.28/share
Bought 32
Tatsis Ourania
Jul 2, 2026 • $524.99/share
Sold 1,500

Recent News